Literature DB >> 11073116

Activating Ly-49D NK receptors: expression and function in relation to ontogeny and Ly-49 inhibitor receptors.

J R Ortaldo1, R Winkler-Pickett, G Wiegand.   

Abstract

Developmental changes in the repertoire of activating Ly-49 family members have not been examined previously. In the present study, we have examined the expression and function of the activating Ly-49s (D and H) from birth through 8 weeks of age. We demonstrate that 1) activating Ly-49s are expressed early, 2) their expression intensity is not different from adult NK cells, and 3) activating receptors are functional. Examination of the inhibitory Ly-49s also demonstrated functional capacity immediately upon expression. To examine the kinetics of expression of the repertoire of activating Ly-49 members, we utilized five- and six-color flow cytometric analyses of NK cells from birth through adulthood. Previous studies examining the inhibitory Ly-49 repertoire have proposed that expression is regulated by the product rule. Our results indicated that Ly-49D, which recognizes H-2Dd, had a discordantly high coexpression of the inhibitory Ly-49s that recognized H-2Dd (Ly-49A and Ly-49G2). The product rule of Ly-49 expression does not explain the coexpression of selected activating and inhibitory receptors. This high level of coexpression of H-2Dd recognizing activating and inhibitory Ly-49s suggests an in vivo selection or regulated coexpression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11073116

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  4 in total

1.  Regulation of ITAM-positive receptors: role of IL-12 and IL-18.

Authors:  John R Ortaldo; Robin Winkler-Pickett; Jon Wigginton; Meagan Horner; Earl W Bere; Anna T Mason; Narayan Bhat; James Cherry; Michael Sanford; Deborah L Hodge; Howard A Young
Journal:  Blood       Date:  2005-10-25       Impact factor: 22.113

2.  Cutting edge: Ly49C/I⁻ neonatal NK cells predispose newborns to autoimmune ovarian disease induced by maternal autoantibody.

Authors:  Claudia Rival; Eileen Samy; Yulius Setiady; Kenneth Tung
Journal:  J Immunol       Date:  2013-08-19       Impact factor: 5.422

Review 3.  Application of tissue-specific NK and NKT cell activity for tumor immunotherapy.

Authors:  Jeff J Subleski; Robert H Wiltrout; Jonathan M Weiss
Journal:  J Autoimmun       Date:  2009-08-13       Impact factor: 7.094

Review 4.  The unique neonatal NK cells: a critical component required for neonatal autoimmune disease induction by maternal autoantibody.

Authors:  Claudia Rival; Yulius Setiady; Eileen T Samy; Jessica Harakal; Kenneth S K Tung
Journal:  Front Immunol       Date:  2014-05-28       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.